Brind.

Quest Diagnostics and Coriell Life Sciences jointly provide advanced pharmacogenomic testing service.

1 report, 1 independent Updated Sep 4

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Quest Diagnostics

Keep exploring

The entities involved

Quest Diagnostics
medical research company
- Market share and investment focus comparison between Quest Diagnostics and GeneDx Holdings Corp. is underway.Mon 12:54
- Quest Diagnostics made required filings with the Securities and Exchange Commission regarding share holdings on June 18, 2026.Mon 10:44

Coverage

Newest first; wire copies grouped

Sep 4PR NewswireQuest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering New Service Empowers Clinicians with Personalized Insights from Coriell Life Sciences to Optimize Prescribing Across Specialties SE